[Official] UK easing all ****en restrictions amid covid (STAY TUNED) by AnubiS - Page 2 - TribalWar Forums
Click Here to find great hosting deals from Branzone.com


Go Back   TribalWar Forums > TribalWar Community > General Discussion
Reload this Page [Official] UK easing all ****en restrictions amid covid (STAY TUNED)
Page 2 of 6
Thread Tools
Edofnor
VeteranXV
Old
21 - 07-19-2021, 23:55
Reply With Quote
ok so they were like "let's move the roids 2 earth orbit 4 cheaper/easier resource extraction" but fking carl didn't sig fig his calculus and now there's a big fking dent next 2 mexico and no dinosaurs (except 4 boombers like u of coarse)
 
Edofnor is offline
 
Sponsored Links
Brasstax
VeteranXX
Contributor
Old
22 - 07-19-2021, 23:57
Reply With Quote
Chicxulub is hot property right now.
 
Brasstax is offline
 
Flash
VeteranXX
Contributor
Old
23 - 07-20-2021, 00:01
Reply With Quote
What a wonderful feeling to depend on my immune system instead of big pharma to save me.
 
Flash is offline
 
Brasstax
VeteranXX
Contributor
Old
24 - 07-20-2021, 00:14
Reply With Quote
Yep - I'm with you on that one. I might get a shot at some point, just not now. Maybe GenII or 3 depending. In the meantime, they sure put the hammer down on anything new. Like Molnupiravir. Which, seems to have had the brakes applied. Almost as if Merk was told when to plan the release for. Like, 2022 or 3.

My belief is that if it is needed, they are ready to pump the **** out like water. But, due to the desire to shoot everyone up with liquid it is felt this would be a distraction. Just me, though. What do I know.

Latest update from July 12th.

Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19, Presented at the European Congress of Clinical Microbiology Infectious Diseases (ECCMID) - Drugs.com MedNews

Quote:
Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19, Presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE) July 12, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced today the presentation of previously announced Phase 2 interim results from two Phase 2/3 clinical trials (MOVe-OUT and MOVe-IN) of molnupiravir (MK-4482/EIDD-2801), an investigational oral antiviral therapeutic. The data were presented during the late-breaking clinical trials session at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). The Phase 3 portion of the global MOVe-OUT trial studying molnupiravir in non-hospitalized adult patients with laboratory-confirmed COVID-19 and at least one risk factor associated with poor disease outcomes is underway. In addition, Merck plans to initiate a clinical program to evaluate molnupiravir for post-exposure prophylaxis in the second half of 2021.

***8220;It continues to be critically important to advance potential antiviral treatments to address the devastating impact of COVID-19 globally,***8221; said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. ***8220;If successful, molnupiravir could help address the continued urgent need for therapeutics.***8221;

***8220;These data are promising, and we are pleased to be able to present the Phase 2 interim results for molnupiravir while we proceed with the Phase 3 portion of MOVe-OUT in non-hospitalized patients,***8221; said Wendy Holman, chief executive officer, Ridgeback Biotherapeutics. ***8220;There remains a great need for a range of solutions for the pandemic, and we are hopeful that molnupiravir will play a role in helping patients.***8221;

For further information regarding our clinical trials, please visit A Novel Coronavirus 19 (COVID-19) Treatment Study or Home - ClinicalTrials.gov.

About Molnupiravir

Molnupiravir (EIDD-2801/MK-4482) is an investigational, orally bioavailable form of a potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. Molnupiravir has been shown to be active in several models of SARS-CoV-2, including for prophylaxis, treatment, and prevention of transmission, as well as SARS-CoV-1 and MERS. EIDD-2801 was invented at Drug Innovations at Emory (DRIVE), LLC, a not-for-profit biotechnology company wholly owned by Emory University and is being developed by Merck & Co., Inc. in collaboration with Ridgeback Biotherapeutics. Since licensed by Ridgeback, all funds used for the development of EIDD-2801/MK-4482 have been provided by Wayne and Wendy Holman and Merck.

About Ridgeback Biotherapeutics

Headquartered in Miami, Florida, Ridgeback Biotherapeutics LP is a biotechnology company focused on emerging infectious diseases. Ridgeback markets EbangaTM for the treatment of Ebola and has a late-stage development pipeline which includes molnupiravir for the treatment of COVID-19. Development of molnupiravir is entirely funded by Ridgeback Biotherapeutics and Merck & Co., Inc. All equity capital in Ridgeback Biotherapeutics LP originated from Wayne and Wendy Holman, who are committed to investing in and supporting medical technologies that will save lives. The team at Ridgeback Biotherapeutics is dedicated to working toward finding life-saving and life-changing solutions for patients and diseases that need champions.

About Merck

For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world***8217;s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals ***8211; including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases ***8211; as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit Merck | Home and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the ***8220;company***8221;) includes ***8220;forward-looking statements***8221; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company***8217;s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company***8217;s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company***8217;s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company***8217;s 2020 Annual Report on Form 10-K and the company***8217;s other filings with the Securities and Exchange Commission (SEC) available at the SEC***8217;s Internet site (SEC.gov | HOME).

Source: Merck
 
Brasstax is offline
 
Nicodemus
VeteranXX
Old
25 - 07-20-2021, 05:12
Reply With Quote
Just nuke china so nobody has a stupid ass ****in urge to eat a ****ing bat again. Who the **** eats a bat? Honestly.

This **** destroyed the planet.
 
Nicodemus is online now
 
Amadeus
VeteranXV
Contributor
Old
26 - 07-20-2021, 05:27
Reply With Quote
Quote:
Originally Posted by Brasstax View Post
Just because someone says you can do something doesn't mean you should.
that sounds like communist statist propaganda to me, **** off with that anti-freedom ****

we love america here
 
Amadeus is offline
 
AnubiS
VeteranXV
Old
27 - 07-20-2021, 08:09
Reply With Quote
UK's Update #2 July 19 2021
By the end of September, "proof of a negative test will no longer be enough," says the prime minister Crooked Boris Johnson - BBC News
"Easing restrictions", forcing people to get vaccinated and carry a covid passport!
That was... Fast!

**** these hypocrites!
 
AnubiS is offline
 
ArakAtak
VeteranXV
Old
29 - 07-20-2021, 10:41
Reply With Quote
Quote:
Originally Posted by Nicodemus View Post
Just nuke china so nobody has a stupid ass ****in urge to eat a ****ing bat again. Who the **** eats a bat? Honestly.

This **** destroyed the planet.

you really think this came from someone eating a bat ...
 
ArakAtak is offline
 
Validuz
VeteranXX
Contributor
Old
30 - 07-20-2021, 10:54
Reply With Quote
Quote:
Originally Posted by Nicodemus View Post
Just nuke china so nobody has a stupid ass ****in urge to eat a ****ing bat again. Who the **** eats a bat? Honestly.

This **** destroyed the planet.
Have you been living under a rock for almost two years? It came from their virology lab, not a bat.
 
Validuz is offline
 
Nicodemus
VeteranXX
Old
31 - 07-20-2021, 12:07
Reply With Quote
 
Nicodemus is online now
 
Lozza Mate
VeteranXX
Contributor
Old
32 - 07-20-2021, 13:10
Reply With Quote
Quote:
Originally Posted by AnubiS View Post
UK's Update #2 July 19 2021
By the end of September, "proof of a negative test will no longer be enough," says the prime minister Crooked Boris Johnson - BBC News
"Easing restrictions", forcing people to get vaccinated and carry a covid passport!
That was... Fast!

**** these hypocrites!
fake news

Quote:
For domestic purposes, those 18 and over can obtain an NHS COVID Pass if one of the following applies:
  • 2 weeks after completing a full course of vaccination, whether that requires 2 doses or one dose (that is, 2 doses of the Moderna, AstraZeneca or Pfizer vaccine, or 1 dose of the Janssen vaccine) (according to the Medicines and Healthcare products Regulatory Agency authorised schedule).
  • with evidence of a negative polymerase chain reaction (PCR) or rapid lateral flow test taken within 48 hours of entry to a venue, with both at-home and on-site (where available) being accepted. A lateral flow test taken at home will need to be reported into the public reporting system
  • with proof of natural immunity shown by a positive PCR test result for COVID-19, lasting for 180 days from the date of the positive test and following completion of the self-isolation period
(source: https://www.gov.uk/guidance/nhs-covid-pass )
 
Lozza Mate is offline
 
Plasmatic
VeteranXV
Old
33 - 07-20-2021, 13:41
Reply With Quote
Quote:
Originally Posted by Nicodemus View Post
Just nuke china so nobody has a stupid ass ****in urge to eat a ****ing bat again. Who the **** eats a bat? Honestly.

This **** destroyed the planet.
It wasn't a bat. The virus was created in the Wuhan lab, we were funding it.
 
Plasmatic is offline
 
Mitchdubai
Pooptruck++
Old
35 - 07-20-2021, 16:36
Reply With Quote
Quote:
Originally Posted by Plasmatic View Post
It wasn't a bat. The virus was created in the Wuhan lab, we were funding it.
Well your kind eat plenty of roadkill and there's nothing wro......oh never mind.
 
Mitchdubai is online now
 
Amadeus
VeteranXV
Contributor
Old
36 - 07-20-2021, 16:41
Reply With Quote
do you think you could pick a more cartoonishly phony "science" site
 
Amadeus is offline
 
FiEND
VeteranXX
Old
37 - 07-20-2021, 16:48
Reply With Quote
^ Lytton BC burned to the ground about the same time as that article... gotta be some kind of cover up burn the evidence thing ^
 
FiEND is offline
 
AnubiS
VeteranXV
Old
38 - 07-20-2021, 19:14
Reply With Quote
Dr Charles Hoffe MD, in his latest update of July 6, 2021 is reporting on the disturbing findings in his patients. He says the mRNA vaccines are plugging up thousands of tiny capillaries in the blood of those who took the ***8216;vaccine.***8217; Most will die in a few short years from heart failure.

July 7, 2021:

http://www.youtube.com/watch?v=r78gATtfRaI

Nothing to see here

Meanwhile

 
AnubiS is offline
 
Last edited by AnubiS; 07-20-2021 at 19:27..
Amadeus
VeteranXV
Contributor
Old
39 - 07-21-2021, 07:39
Reply With Quote
what a prediction

"a lot of people will die from heart failure in the next couple years"

this is in contrast to how normally, nobody ever dies from heart failure, right?
 
Amadeus is offline
 
ArakAtak
VeteranXV
Old
40 - 07-21-2021, 07:55
Reply With Quote
Quote:
***8220;We now know that only 25 percent of the ***8216;vaccine***8217; injected into a person***8217;s arm actually stays in your arm. The other 75 percent is collected by your lymphatic system and literally fed into your circulation
My wife got her second Pfizer a few days ago and has been really sick since then (fever + whatnot). The lymph glands in her armpits have now swollen so large she can hardly lower her arms and is in a lot of pain. That **** has ****ed her up, no question.

Hoping it tones down by tomorrow or it's off to the hospital.

I was booked in for next week but I might cancel having seen this, I've never seen her so sick in the 25+yrs we have been together.
 
ArakAtak is offline
 
Page 2 of 6
Reply


Go Back   TribalWar Forums > TribalWar Community > General Discussion
Reload this Page [Official] UK easing all ****en restrictions amid covid (STAY TUNED)

Social Website Bullshit

Tags
fuck covid passports


Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


AGENT: CCBot/2.0 (https://commoncrawl.org/faq/) / Y
All times are GMT -4. The time now is 03:44.